194
Views
2
CrossRef citations to date
0
Altmetric
Scientific Articles

Protection of sheep by vaccination against experimental challenge with Leptospira borgpetersenii serovar Hardjo and L. interrogans serovar Pomona

, , , &
Pages 138-143 | Received 23 Jul 2017, Accepted 24 Jan 2018, Published online: 08 Mar 2018

References

  • Allen JD, Meney CL, Wilks CR. Evaluation of a hardjo-pomona vaccine to prevent leptospiruria in cattle exposed to a natural challenge with Leptospira interrogans serovar Hardjo. Australian Veterinary Journal 58, 93–6, 1982 doi: 10.1111/j.1751-0813.1982.tb00598.x
  • *Anonymous. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 6th Edtn. http://www.oie.int/manual-of-diagnostic-tests-and-vaccines-for-terrestrial-animals/ (accessed 31 March 2015). Office International Des Epizooties, Paris, France, 2008.
  • Bolin CA, Alt DP. Use of a monovalent leptospiral vaccine to prevent renal colonization and urinary shedding in cattle exposed to Leptospira borgpetersenii serovar Hardjo. American Journal of Veterinary Research 62, 995–1000, 2001 doi: 10.2460/ajvr.2001.62.995
  • Brown RA, Blumerman S, Gay C, Bolin C, Duby R, Baldwin CL. Comparison of three different leptospiral vaccines for induction of a type 1 immune response to Leptospira borgpetersenii serovar Hardjo. Vaccine 21, 4448–58, 2003 doi: 10.1016/S0264-410X(03)00439-0
  • Dorjee S, Heuer C, Jackson R, West DM, Collins-Emerson JM, Midwinter AC, Ridler AL. Prevalence of pathogenic Leptospira spp. in sheep in a sheep-only abattoir in New Zealand. New Zealand Veterinary Journal 56, 164–70, 2008 doi: 10.1080/00480169.2008.36829
  • Dorjee S, Heuer C, Jackson R, West DM, Collins-Emerson JM, Midwinter AC, Ridler AL. Assessment of occupational exposure to leptospirosis in a sheep-only abattoir. Epidemiology and Infection 139, 797–806, 2011 doi: 10.1017/S0950268810002049
  • *Dreyfus A. Leptospirosis in humans and pastoral livestock in New Zealand. PhD thesis, Massey University, Palmerston North, New Zealand, 2013
  • *Faine S, Adler B, Bolin C, Perolat P. Clinical laboratory diagnosis of leptospirosis. Leptospira and Leptospirosis 1, 229–42, 1999
  • Fang F, Collins-Emerson JM, Cullum A, Heuer C, Wilson PR, Benschop J. Shedding and seroprevalence of pathogenic Leptospira spp. in sheep and cattle at a New Zealand abattoir. Zoonoses and Public Health 62, 258–68, 2015 doi: 10.1111/zph.12146
  • *Heuer C, Wilson P, Benschop J, Collins-Emerson J, Dreyfus A, Sanhueza J. Leptospirosis news: production effects and public health. Proceedings of the Society of Dairy Cattle Veterinarians of the New Zealand Veterinary Association. Pp 2.14.1–2.14.7, 2012
  • *Little P, Hodge A, Booth K, Clough W. Twelve months duration of immunity following two doses of Ultravac 7 in 1 vaccine, administered to calves at 6–8 and 12–14 weeks of age, assessed by challenge with Leptospira borgpetersenii serovar Hardjo. Proceedings of the XXVIII World Buiatrics Congress. P 147, 2014
  • Marshall RB, Manktelow BW. Fifty years of leptospirosis research in New Zealand: a perspective. New Zealand Veterinary Journal 50, 61–3, 2002 doi: 10.1080/00480169.2002.36270
  • Marshall RB, Broughton ES, Hathaway SC. Protection of sheep by vaccination against artificial challenge with Leptospira interrogans serovar Hardjo. New Zealand Veterinary Journal 27, 195–6, 1979 doi: 10.1080/00480169.1979.34646
  • Marshall RB, Schollum LM, Dymock BL. Prevention of Leptospira interogans serovar Pomona infection in cattle. New Zealand Veterinary Journal 30, 177–9, 1982 doi: 10.1080/00480169.1982.34933
  • Naiman BM, Alt D, Bolin CA, Zuerner R, Baldwin CL. Protective killed Leptospira borgpetersenii vaccine induces potent Th1 immunity comprising responses by CD4 and gammadelta T lymphocytes. Infection and Immunity 69, 7550–8, 2001 doi: 10.1128/IAI.69.12.7550-7558.2001
  • O’Keefe JS. A brief review on the laboratory diagnosis of leptospirosis. New Zealand Veterinary Journal 50, 9–13, 2002 doi: 10.1080/00480169.2002.36242
  • Ridler AL, Vallee E, Corner RA, Kenyon PR, Heuer C. Factors associated with fetal losses in ewe lambs on a New Zealand sheep farm. New Zealand Veterinary Journal 63, 330–4, 2015 doi: 10.1080/00480169.2015.1037813
  • Rinehart CL, Zimmerman AD, Buterbaugh RE, Jolie RA, Chase CCL. Efficacy of vaccination of cattle with the Leptospira interrogans serovar Hardjo type hardjoprajitno component of a pentavalent Leptospira bacterin against experimental challenge with Leptospira borgpetersenii serovar Hardjo type hardjo-bovis. American Journal of Veterinary Research 73, 735–40, 2012 doi: 10.2460/ajvr.73.5.735
  • Vallée E, Heuer C, Collins-Emerson JM, Benschop J, Wilson PR. Serological patterns, antibody half-life and shedding in urine of Leptospira spp. in naturally exposed sheep. New Zealand Veterinary Journal 63, 301–12, 2015 doi: 10.1080/00480169.2015.1049668
  • Vallée E, Ridler AL, Heuer C, Collins-Emerson JM, Benschop J, Wilson PR. Effectiveness of a commercial leptospiral vaccine on urinary shedding in naturally exposed sheep in New Zealand. Vaccine, 35, 1362–8, 2017 doi: 10.1016/j.vaccine.2016.04.037
  • Vermunt JJ, West DM, Cooke MM, Alley MR, Collins-Emerson J. Observations on three outbreaks of Leptospira interrogans serovar Pomona infection in lambs. New Zealand Veterinary Journal 42, 133–6, 1994 doi: 10.1080/00480169.1994.35803
  • Webster WM, Reynolds BA. Immunization against Leptospira pomona. New Zealand Veterinary Journal 3, 47–59, 1955 doi: 10.1080/00480169.1955.33178
  • Zimmerman AD, Springer EW, Barling KS, Buterbaugh RE, Pooley RD, Scholz DA, Rhoades JR, Chase CCL. Immunity in heifers 12 months after vaccination with a multivalent vaccine containing a United States Leptospira borgpetersenii serovar Hardjo isolate. Journal of the American Veterinary Medical Association 242, 1573–7, 2013 doi: 10.2460/javma.242.11.1573
  • Zuerner RL, Alt DP, Palmer MV, Thacker TC, Olsen SC. A Leptospira borgpetersenii serovar Hardjo vaccine induces a Th1 response, activates NK cells, and reduces renal colonization. Clinical and Vaccine Immunology CVI 18, 684–91, 2011 doi: 10.1128/CVI.00288-10

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.